Liu et al. also reported that elevated HOTAIR expression was associated with cisplatin resistance in NSCLC, and showed that HOTAIR expression was directly related to KLF4 expression, suggesting a new therapeutic target for drug-resistance patients with NSCLC [111]. Here, KLF4 is linked to non-small cell lung carcinoma.